<DOC>
	<DOCNO>NCT01627847</DOCNO>
	<brief_summary>This open label , randomise , balance , two-treatment , two-period , two-sequence , crossover , oral bioequivalence study .</brief_summary>
	<brief_title>Bioequivalence Study Ropinirole Hydrochloride ER Tablets 2 mg Under Fed Condition</brief_title>
	<detailed_description>The objective study determine single-dose oral bioequivalence Ropinirole Hydrochloride Extended Release Tablets 2 mg Dr. Reddy 's Laboratories Limited , India REQUIPÂ® XL ( Ropinirole Hydrochloride Extended Release ) 2 mg Tablets Glaxosmithkline , USA , normal , healthy , adult , human subject feed condition .</detailed_description>
	<mesh_term>Ropinirole</mesh_term>
	<criteria>1 . Healthy human subject age 18 45 year ( include ) . 2 . Subjects BMI 18.5 24.9 Kg/m2 ( include ) body weight less 45 Kgs . 3 . Subjects normal health determine personal medical history , clinical examination , laboratory examination include serological test . 4 . Subjects normal 12lead electrocardiogram ( ECG ) . 5 . Subjects normal chest XRay ( PIA view ) . 6 . Subjects able communicate effectively . 7 . Subjects willing give write informed consent adhere requirement protocol . 8 . Female subject postmenopausal surgically sterile . 9 . Female subject practice acceptable method birth control duration study judge investigator ( ) , condom , foam , jelly , diaphragm , intrauterine device ( IUD ) abstinence . 1 . Subjects contraindication hypersensitivity ropinirole domperidone relate group drug . 2 . History presence medical condition disease accord opinion physician . 3 . History presence significant cardiovascular , pulmonary , hepatic , renal , gastrointestinal , endocrine , immunological , dermatological , neurological psychiatric disease disorder . 4 . History presence significant alcoholism drug abuse past one year . 5 . History presence significant smoking ( 10 cigarette bidis/day consumption tobacco product ) . 6 . Difficulty donate blood . 7 . Difficulty swallow solid like tablet capsule . 8 . Systolic blood pressure le 110mm Hg 140 mm Hg . 9 . Diastolic blood pressure le 70 mm Hg 90 mm Hg . 10 . Pulse rate le 50 beats/minute 100 beats/minute . 11 . Use prescribed medication last two week OTC medicinal product last one week precede first dosing . 12 . Major illness 3 month screen . 13 . Participation drug research study within past 3 month . 14 . Donation blood past 3 month screen . 15 . Female subject demonstrate positive pregnancy screen . 16 . Female subject currently breastfeed . 17 . Female subject child bear potential use prohibit contraceptive method ( Oral , Injectable Implantable hormonal agent ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>Bioequivalence</keyword>
	<keyword>Ropinirole Hydrochloride</keyword>
	<keyword>crossover</keyword>
</DOC>